topSkip to main content

Menu, Secondary

Menu Trigger

Menu

National Institutes of Health

Biomedical research funded by the National Institutes of Health (NIH) and performed at research universities helps assure U.S. leadership in the life sciences revolution of the 21st Century. Putting NIH on a sustained pathway to restore its purchasing power after a decade worth of loss to inflation and budget cuts is critical to sustaining the extraordinary progress in the improvement of human health of the past decades. Investment in NIH will continue to create jobs and strengthen the workforce, improve the lives—and quality of life—of millions of current and future patients, and help assure continuing U.S. economic and national security.

Sustained investment in biotechnology and genomics is crucial to the development of novel therapies for diseases, including: cancer, Alzheimer's, autism, and diabetes. The NIH also responds rapidly to public health emergencies and in support of biodefense, such as in the case of Ebola, Zika, and influenza.

 

As lawmakers consider measures related to securing federally funded research data and intellectual property, it is important to understand the current state of play for research security in the country to avoid new requirements that are duplicative, unnecessary, or counterproductive
AAU and others asked the leaders of the House and Senate appropriations committees to include a robust investment of more than $49 billion in the FY23 spending package for the National Institutes of Health.
Representatives André Carson (D-In), David McKinley (R-WV), Suzan DelBene (D-WA), and Brian Fitzpatrick (R-PA) are circulating the below "Dear Colleague" letter encouraging House appropriators to provide for the NIH base budget “at least $49 billion and that any funding for the Advanced Research Projects Agency for Health should supplement, not supplant, this necessary growth in the NIH base budget” in FY23.
An overview of the President's full proposed budget for FY23, including summaries and analyses for individual agencies.
This table represents the current status of FY22 appropriations for AAU’s funding priorities at the Departments of Education, Energy, and Defense as well as the National Institutes of Health (NIH), National Science Foundation (NSF), NASA, AFRI, and the National Endowment for the Humanities (NEH).
AAU urges Congress to provide at least $49 billion for the National Institutes of Health in FY23. NIH contributes to American economic growth and productivity and expands biomedical knowledge by funding cutting-edge research and cultivating the biomedical workforce of today and tomorrow.
United for Medical Research, of which AAU is a founding member, sent a letter urging OMB Acting Director Shalanda Young to include an increase of at least $3 billion to the base budget of the National Institutes of Health for FY23.
United for Medical Research, of which AAU is a founding member, sent letters urging House and Senate leaders to avoid another continuing resolution and to complete FY22 appropriations